Biogen (BIIB)

Company Ticker Sector | Industry Quality PAR
Biogen BIIB Healthcare | Biotechnology 81 17.8%
Current Price (03/26) $232.91
CAPS Rating (Rate this stock on CAPS) Foolcaps 5
Expected Income Statement
Current Sales 13,542.3
Sales Growth Forecast 6.7%
Net Profit Margin 35.4%
Projected Shares Outstanding 200.00
EPS - Five year Forecast $33.09
Average P/E Ratio 16.0
Projected Average Price $529.45
Price Appreciation (Annualized) 17.8%
Annual Dividend Yield 0.0%
Projected Annual Return 17.8%
Quality
Financial Strength 88 22.1
EPS Stability 81 20.3
Industry Sales Growth Rate 16.5% 5.0
Industry Net Profit Margin 29.0% 15.3
Calculated Quality Rating 62.6
Fool CAPS

Total Players

1001 Outperforms
69 Underperforms
 

All-Stars (246)

236 Outperforms (96%)
10 Underperforms
 
Fundamental Data Updated: 01/04/2019

MIPAR 8.9%  
Sweet Spot 13.9% - 18.9%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 92 15.9%
BIIB 81 17.8%
REGN 82 17.0%
CBPO 73 13.9%
AMGN 91 8.5%

Top In Healthcare

Ticker Quality PAR
ABBV 97 16.2%
ALGN 99 15.3%
CMD 92 16.2%
JAZZ 92 15.9%
CNC 80 19.0%